The Cupertino company does not cease in negotiations with other companies in the medical and health sector. In this case Apple's own COO Jeff Williams, was in charge of announcing the partnership with Johnson & Johnson's JNJ company, Janssen Pharmaceuticals, which has several open fronts to improve people's health.
In this case, it is an application related to heart health, which made Apple pay attention to them and thus establish ties between the two companies. In principle, there is talk of using the Apple Watch and this app to accelerate diagnosing and improving screening results for people with atrial fibrillation.
JNJ of Johnson & Johnson, Janssen Pharmaceuticals Inc. Joins the team that works with Apple for health and is not the first but it will not be the last. In recent times Apple is fully involved in health and this is a good business for technology companies like Apple that see a good free vein to investigate and work.
With the Apple watch on the wrist it seems that the main function of this application and the rest of the research will focus on the early detection and diagnosis of AFIB. In this case it is good to say that atrial fibrillation is a condition that affects 33 million people worldwide And the conditions are usually blood clots, strokes, and heart failure. For now, and how could it be otherwise, research and development will be carried out exclusively (at least for now) in the US and the people with whom it is expected to work must be between 65 years old. or more.
